Race Oncology (ASX: RAC) Share Price

RAC

$2.40▲+1.69%

$468.1MRank #473 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$468.1M

Volume

86K

P/E Ratio

-29.29

EPS

-$0.0233

Dividend Yield

0.00%

52-Week High

$4.90

52-Week Low

$1.115

Beta

0.812

Race Oncology (ASX: RAC) is an Australian-listed company in the Healthcare sector with a market capitalisation of $468.1M and the 473rd-largest security on the ASX by market capitalisation. The RAC share price is $2.40, up 1.69% today and up 108.70% over the past 12 months. Shares have traded between $1.115 and $4.90 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Race Oncology reported revenue of $0 and a net loss of $4.1M.

Charts

$2.40

24H Range

$2.38

$2.46

52-Week Range

$1.115

$4.90

About Race Oncology Limited

Headquartered in Sydney, Australia, Race Oncology Limited is a precision oncology company focused on advancing its lead therapeutic, Zantrene. This potent small molecule compound acts as an inhibitor of the fatso/fat mass and obesity associated protein (FTO) and is currently undergoing Phase II/III clinical trials. Zantrene is being investigated for its potential to treat a range of cancers, including melanoma, clear cell renal cell carcinoma, acute myeloid leukaemia, breast cancer, and ovarian cancer. The company maintains an active preclinical research program with the University of Newcastle, focusing on Zantrene, and has also forged a strategic alliance with the University of Wollongong to assess various formulations of the drug. Established in 2011, Race Oncology Limited adopted its current name in July 2016, having previously operated as Coronado Resources Limited.

IPO Date

13 July 2016

CEO

Daniel Tillett

Website

raceoncology.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-4.1M
Total Assets	$24.8M
Total Debt	$0
Free Cash Flow	$-2.2M
Return on Equity	-17.39%
Profit Margin	—
Operating Margin	—

RAC Frequently Asked Questions

What is the Race Oncology (ASX: RAC) share price?

The RAC share price is $2.40, up 1.69% for the day, based on the latest available ASX market data.

What is Race Oncology's market capitalisation?

Race Oncology has a market capitalisation of $468.1M, making it the 473rd-largest security listed on the ASX.

Does Race Oncology pay a dividend?

RAC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Race Oncology profitable?

In its most recent reported period (ending 31 Dec 2025), RAC reported revenue of $0 and a net loss of $4.1M.

How many RAC shares are on issue?

Race Oncology has approximately 195,033,420 shares on issue, based on its market capitalisation of $468.1M and current share price.

What sector is Race Oncology in?

Race Oncology is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Race Oncology list on the ASX?

Race Oncology listed on the Australian Securities Exchange on 13 July 2016.

Latest News

Kalkine ASX Spotlight: What Weighed on Race Oncology (ASX:RAC) Shares Today?

Kalkine11 June 2026

Kalkine ASX Spotlight: What Weighed on Race Oncology (ASX:RAC) Shares Today? Kalkine

Racura Oncology Ltd (ASX: RAC) - Share Price

intelligentinvestor.com.au9 Dec 2025

Racura Oncology Ltd (ASX: RAC) - Share Price intelligentinvestor.com.au

Race Oncology changes name to Racura Oncology as HARNESS-1 trial gains momentum

Proactive financial news10 Dec 2025

Race Oncology changes name to Racura Oncology as HARNESS-1 trial gains momentum Proactive financial news

Insights: Racura Oncology Ltd (ASX:RAC)

smallcaps.com.au30 Oct 2025

Insights: Racura Oncology Ltd (ASX:RAC) smallcaps.com.au

Cancer drug developer’s shares race to three-year high, up 20% on new research results

The Motley Fool Australia2 Oct 2025

Cancer drug developer’s shares race to three-year high, up 20% on new research results The Motley Fool Australia

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
CGSCogstate Limited	$465.5M	$2.74	20.94	0.59%	▼-0.36%
CUVClinuvel Pharmaceuticals Limited	$451.7M	$8.96	14.96	0.40%	▲+1.24%
OCAOceania Healthcare Limited	$420.1M	$0.58	-26.28	0.00%	▲+0.87%
ACLAustralian Clinical Labs Limited	$405.4M	$2.16	23.92	3.29%	–+0.00%
HLSHealius Limited	$261.4M	$0.36	-5.40	0.00%	▲+5.88%
PGCParagon Care Limited	$248.3M	$0.15	-4.18	0.00%	▼-3.23%
EBREBR Systems, Inc.	$169.0M	$0.375	-28.93	0.00%	–+0.00%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.41	$2.46	$2.38	$2.40	85K	▲+1.69%
11 June 2026	$2.40	$2.45	$2.29	$2.36	127K	▼-0.84%
10 June 2026	$2.54	$2.54	$2.38	$2.38	171K	▼-7.39%
9 June 2026	$2.70	$2.70	$2.56	$2.57	92K	▼-4.81%
8 June 2026	$2.78	$2.89	$2.63	$2.70	116K	▲+0.75%
5 June 2026	$2.78	$2.89	$2.63	$2.68	112K	▼-2.90%
4 June 2026	$2.48	$2.78	$2.40	$2.76	300K	▲+9.96%
3 June 2026	$2.60	$2.60	$2.38	$2.51	87K	▲+1.21%
2 June 2026	$2.66	$2.66	$2.45	$2.48	206K	▼-7.12%
1 June 2026	$2.58	$2.71	$2.58	$2.67	78K	▲+3.49%
29 May 2026	$2.55	$2.61	$2.48	$2.58	118K	▲+1.98%
28 May 2026	$2.75	$2.75	$2.525	$2.53	45K	▼-6.64%
27 May 2026	$2.53	$2.73	$2.52	$2.71	136K	▲+6.69%
26 May 2026	$2.55	$2.60	$2.47	$2.54	107K	▲+2.01%
25 May 2026	$2.50	$2.58	$2.46	$2.49	145K	▲+0.40%
22 May 2026	$2.49	$2.54	$2.43	$2.48	162K	▲+0.40%
21 May 2026	$2.46	$2.52	$2.45	$2.47	119K	▲+2.07%
20 May 2026	$2.50	$2.52	$2.42	$2.42	157K	▼-2.02%
19 May 2026	$2.68	$2.68	$2.44	$2.47	126K	▼-5.73%
18 May 2026	$2.74	$2.75	$2.61	$2.62	119K	▼-3.85%
15 May 2026	$2.67	$2.95	$2.64	$2.725	270K	▲+6.03%
14 May 2026	$2.65	$2.68	$2.54	$2.57	141K	▼-2.28%
13 May 2026	$2.73	$2.75	$2.62	$2.63	141K	▼-3.31%
12 May 2026	$2.78	$2.97	$2.72	$2.72	202K	▼-1.45%
11 May 2026	$2.73	$2.78	$2.66	$2.76	79K	▲+1.85%
8 May 2026	$2.50	$2.76	$2.48	$2.71	247K	▲+9.27%
7 May 2026	$2.36	$2.50	$2.36	$2.48	158K	▲+4.64%
6 May 2026	$2.40	$2.45	$2.32	$2.37	173K	▼-2.07%
5 May 2026	$2.62	$2.64	$2.42	$2.42	206K	▼-7.63%
4 May 2026	$2.65	$2.67	$2.56	$2.62	137K	–+0.00%

About Race Oncology Limited

IPO Date

13 July 2016

CEO

Daniel Tillett

Website

raceoncology.com

RAC Frequently Asked Questions

What is the Race Oncology (ASX: RAC) share price?

The RAC share price is $2.40, up 1.69% for the day, based on the latest available ASX market data.

What is Race Oncology's market capitalisation?

Race Oncology has a market capitalisation of $468.1M, making it the 473rd-largest security listed on the ASX.

Does Race Oncology pay a dividend?

RAC does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Race Oncology profitable?

In its most recent reported period (ending 31 Dec 2025), RAC reported revenue of $0 and a net loss of $4.1M.

How many RAC shares are on issue?

Race Oncology has approximately 195,033,420 shares on issue, based on its market capitalisation of $468.1M and current share price.

What sector is Race Oncology in?

Race Oncology is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Race Oncology list on the ASX?

Race Oncology listed on the Australian Securities Exchange on 13 July 2016.

Company

Market Cap

Price

P/E

Div Yield

1D Change

PYCPYC Therapeutics Limited

$711.3M

$1.22

-10.86

0.00%

▲+3.39%

CGSCogstate Limited

$465.5M

$2.74

20.94

0.59%

▼-0.36%

CUVClinuvel Pharmaceuticals Limited

$451.7M

$8.96

14.96

0.40%

▲+1.24%

OCAOceania Healthcare Limited

$420.1M

$0.58

-26.28

0.00%

▲+0.87%

ACLAustralian Clinical Labs Limited

$405.4M

$2.16

23.92

3.29%

–+0.00%

HLSHealius Limited

$261.4M

$0.36

-5.40

0.00%

▲+5.88%

PGCParagon Care Limited

$248.3M

$0.15

-4.18

0.00%

▼-3.23%

EBREBR Systems, Inc.

$169.0M

$0.375

-28.93

0.00%

–+0.00%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.41	$2.46	$2.38	$2.40	85K	▲+1.69%
11 June 2026	$2.40	$2.45	$2.29	$2.36	127K	▼-0.84%
10 June 2026	$2.54	$2.54	$2.38	$2.38	171K	▼-7.39%
9 June 2026	$2.70	$2.70	$2.56	$2.57	92K	▼-4.81%
8 June 2026	$2.78	$2.89	$2.63	$2.70	116K	▲+0.75%
5 June 2026	$2.78	$2.89	$2.63	$2.68	112K	▼-2.90%
4 June 2026	$2.48	$2.78	$2.40	$2.76	300K	▲+9.96%
3 June 2026	$2.60	$2.60	$2.38	$2.51	87K	▲+1.21%
2 June 2026	$2.66	$2.66	$2.45	$2.48	206K	▼-7.12%
1 June 2026	$2.58	$2.71	$2.58	$2.67	78K	▲+3.49%
29 May 2026	$2.55	$2.61	$2.48	$2.58	118K	▲+1.98%
28 May 2026	$2.75	$2.75	$2.525	$2.53	45K	▼-6.64%
27 May 2026	$2.53	$2.73	$2.52	$2.71	136K	▲+6.69%
26 May 2026	$2.55	$2.60	$2.47	$2.54	107K	▲+2.01%
25 May 2026	$2.50	$2.58	$2.46	$2.49	145K	▲+0.40%
22 May 2026	$2.49	$2.54	$2.43	$2.48	162K	▲+0.40%
21 May 2026	$2.46	$2.52	$2.45	$2.47	119K	▲+2.07%
20 May 2026	$2.50	$2.52	$2.42	$2.42	157K	▼-2.02%
19 May 2026	$2.68	$2.68	$2.44	$2.47	126K	▼-5.73%
18 May 2026	$2.74	$2.75	$2.61	$2.62	119K	▼-3.85%
15 May 2026	$2.67	$2.95	$2.64	$2.725	270K	▲+6.03%
14 May 2026	$2.65	$2.68	$2.54	$2.57	141K	▼-2.28%
13 May 2026	$2.73	$2.75	$2.62	$2.63	141K	▼-3.31%
12 May 2026	$2.78	$2.97	$2.72	$2.72	202K	▼-1.45%
11 May 2026	$2.73	$2.78	$2.66	$2.76	79K	▲+1.85%
8 May 2026	$2.50	$2.76	$2.48	$2.71	247K	▲+9.27%
7 May 2026	$2.36	$2.50	$2.36	$2.48	158K	▲+4.64%
6 May 2026	$2.40	$2.45	$2.32	$2.37	173K	▼-2.07%
5 May 2026	$2.62	$2.64	$2.42	$2.42	206K	▼-7.63%
4 May 2026	$2.65	$2.67	$2.56	$2.62	137K	–+0.00%